MJardin Group Reaches a Major Milestone In Its Debt Amendment Process

DENVER, Colorado, and TORONTO, Canada, May 29, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that the Company has agreed with its senior lender to amend certain terms associated with its borrowing obligations (the “Agreement”).

 The Agreement provides for a revised maturity of MJardin’s senior debt to April 2021 and removes the callable nature of the loan. In addition, the senior lender has agreed to provide up to CAD$20MM in additional borrowings.

MJardin Announces Construction Completion of its 3rd Canadian Cultivation Facility

TORONTO, Canada and DENVER, Colorado, May 28, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that it has completed construction of “GRO”, an indoor cannabis cultivation facility located in Dunnville, Ontario and has submitted its Evidence of Readiness package to Health Canada. The facility is a joint-venture between MJardin Group (75%) and Grand River Organics (25%).  

MJardin Provides Update On its Retail Parternship With Peguis

TORONTO, Canada and DENVER, Colorado, May 21, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, congratulates its cannabis retail partner Peguis First Nation on their significant investment and historical milestone in Selkirk, Manitoba.

MJardin Group to Issue First Quarter 2019 Financial Results May 30, 2019

TORONTO, Canada and DENVER, Colorado, May 16, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce that it will report its first quarter 2019 financial results for the period ended March 31, 2019, before market open on May 30, 2019.

 The Company will host a conference call on the same day at 10:00 am ET. Adrian Montgomery, Chairman, and Chris Seto, Chief Financial Officer, will discuss the Company’s financial performance for the period ended March 31, 2019.

To access the call, please dial 1-800-458-4121 or 1-323-794-2093. A replay of the conference call will be available from 1:00 pm ET on May 30, 2019, until 11:59 pm ET, June 13, 2019. To access the replay, call 1-844-512-2921 or 1-412-317-6671, followed by passcode 6223360.

A webcast link to the call is available at the following URL: http://public.viavid.com/index.php?id=134637

MJardin to Present at the 3rd Annual Canaccord Genuity Cannabis Conference

Company will Provide Growth Strategy and Meet with Investors

DENVER, Colorado, and TORONTO, Canada May 13, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, announced today that the Company will present at the 3rd Annual Canaccord Genuity Cannabis Conference.

Adrian Montgomery, Chairman and Interim Chief Executive Officer, and Chris Seto, Chief Financial Officer, will present on the Company’s growth strategy and will be joined by Board member James Lowe, Founder of MJardin Group, to meet with investors. The formal presentation is scheduled for 2:00 pm ET on Tuesday, May 14, 2019 at the Grand Hyatt New York, in New York City and can be found on the Company’s website at http://investors.mjardin.com/Investor-Presentations.

MJardin Group Announces Fourth Quarter and Full Year 2018 Financial Results

DENVER, Colorado, and TORONTO, Canada, May 7, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in premium cannabis production, today announced its financial and operating results for the year ending December 31, 2018. All amounts are expressed in Canadian dollars unless otherwise indicated.

·       Revenue increased 38% Y-o-Y to $27.5 million;

·       Completed the acquisition of GrowForce Holdings Inc. (“GrowForce”), a Canadian LP with a footprint in 3 Canadian provinces, estimated run rate production of 24,400 KG and strong strategic relationships with several First Nations; 

·       Completed the acquisition of the assets of F&L Investments LLC (“Cheyenne”), a facility located in Las Vegas, Nevada, with expected production capacity of approximately 5,800 KG;

·       Received Cultivation and Sale licenses for the Company’s facility located in Brampton, ON (“WILL”) and completed first sale of product;

·       From the first harvest in May 2018, MJardin’s WILL facility has produced average yields of 87 grams of flower and extractable trim per square foot of bench space, which management believes to be amongst the top yields in the industry.

MJardin Announces the Acquisition of Cannabella - Acquisition Adds Extraction Capabilities and Consumer Products to the Company’s Nevada Portfolio

DENVER, Colorado, and TORONTO, Canada, April 22, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in cannabis production, announced today that it has entered into a definitive agreement (the “Transaction”) to acquire Carson City Agency Solutions, dba Cannabella, an operator of an extraction facility and producer of edibles and topicals in Carson City, Nevada.

MJardin’s Atlantic Canada Facility Reaches Full Production Capacity in 4 Months

Nova Scotia Mi’kmaq First Nations, Halef Group, and MJardin Expect Sales License this Spring

TORONTO, Canada and DENVER, Colorado, April 18, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce that its joint-venture AtlantiCann Medical Inc. (“AMI”) facility located in Lower Sackville, Nova Scotia has now reached its full production capacity in an impressive four months since receiving its cultivation and processing license on December 7, 2018.  AMI is a three-way joint-venture consisting of Nova Scotia Mi’kmaq First Nations (51%), MJardin Group, Inc. (39%) and the Halef Group (10%).

MJardin’s Ontario Cultivation Facility Exceeds Historical Company Yields - Successfully Scaling High Yield Cannabis Production Across Borders

TORONTO, Canada and DENVER, Colorado, April 15, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), is pleased to announce what the company believes to be industry leading yield numbers from its “WILL” facility in Brampton, Ontario. “WILL” was the first of the Company’s Canadian asset portfolio to be federally licensed for cultivation and sales by Health Canada.

MJardin Announces Nova Scotia Mi’kmaq First Nations Joining its AMI Partnership

 

TORONTO, Canada and DENVER, Colorado, April 1, 2019 -- MJardin Group, Inc. (“MJardin” or “the Company”) (CSE: MJAR) (OTCQX: MJARF), a leader in cannabis production, is pleased to announce the completion of an Agreement (the “Agreement”), whereby the Nova Scotia Mi’kmaq First Nations (“Mi’kmaq”) will own a 51% stake in AtlantiCann Medical Inc. (“AMI”). As a result of the Agreement, MJardin and the Halef Group will own 39% and 10% of AMI, respectively. In connection with the partnership formed under the Agreement, MJardin, the Mi’kmaq and the Halef Group are contemplating expansion of their relationship, including retail.